Reaction Details Report a problem with these data
Target
Egl nine homolog 1 [181-417]
Ligand
BDBM413317
Substrate
n/a
Meas. Tech.
Inhibition Assay
IC50
4.37±n/a nM
Citation
 Brown, JW; Davis, M; Ivetac, A; Jones, B; Kiryanov, AA; Kuehler, J; Lanier, M; Miura, J; Murphy, S; Wang, X 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD US Patent  US10407409 Publication Date 9/10/2019 
Target
Name:
Egl nine homolog 1 [181-417]
Synonyms:
C1orf12 | EGLN1 | EGLN1_HUMAN | Egl nine homolog 1 (aa 181-417)
Type:
Enzyme
Mol. Mass.:
26555.51
Organism:
Homo sapiens (Human)
Description:
aa 181-417
Residue:
237
Sequence:
PNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKP
  
Inhibitor
Name:
BDBM413317
Synonyms:
6-(4-(4-cyanophenyl)-5-hydroxy-1H-pyrazol-1-yl)-N-(1-(2-methoxy ethyl)cyclopentyl)nicotinamide | US10407409, Example 354
Type:
Small organic molecule
Emp. Form.:
C24H25N5O3
Mol. Mass.:
431.487
SMILES:
COCCC1(CCCC1)NC(=O)c1ccc(nc1)-n1ncc(c1O)-c1ccc(cc1)C#N
Structure:
Search PDB for entries with ligand similarity: